AASHIKA JALADI: Open Payments
NPI 1558905281 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 49 payments from 12 companies in 2025. Trend: 2023 $1,105 · 2024 $1,020 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $273 |
| Actelion Pharmaceuticals US, Inc. | 8 | $132 |
| Boston Scientific Corporation | 6 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| BIOTRONIK INC. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: REPATHA, WATCHMAN FLX, UPTRAVI, LEQVIO, Adempas, Kerendia, OPSUMIT, BIOMONITOR.
Industry payments across NJ — which companies pay providers there.
